发明名称 |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
摘要 |
Inhibitors of HBV replication of formula (I);
including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R1 to R7 have the meaning as defined herein.
;The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy. |
申请公布号 |
US9567299(B2) |
申请公布日期 |
2017.02.14 |
申请号 |
US201415031493 |
申请日期 |
2014.10.22 |
申请人 |
JANSSEN SCIENCES IRELAND UC |
发明人 |
Vandyck Koen;Haché Geerwin Yvonne Paul;Kesteleyn Bart Rudolf Romanie;Raboisson Pierre Jean-Marie Bernard |
分类号 |
C07D207/18;A61K31/40;C07D207/09;C07D405/12;C07D207/16;C07D211/60;A61K31/445;A61K45/06;C07D211/34 |
主分类号 |
C07D207/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of Formula (I) or a stereoisomer or tautomeric form thereof, wherein:is each of Ra, Rb, Rc, Rd, Re, Rf and Rg are independently selected from the group consisting of hydrogen and methyl; Rh is hydrogen; Ri is hydrogen; R1, R2 and R3 are independently selected from the group consisting of hydrogen, fluoro, chloro, bromo, —CHF2, —CH2F, —CF3, —CN and methyl; R6 is selected from the group consisting of C1-C6alkyl and a 3-7 membered saturated ring optionally containing one or more heteroatoms each independently selected from the group consisting of O, S and N, said C1-C6alkyl and 3-7 membered saturated ring each optionally substituted with one or more substituents selected from the group consisting of fluoro and C1-C3alkyl, wherein said C1-C3alkyl is optionally substituted with one or more substituents selected from the group consisting of fluoro, —CN, and OH; R7 is hydrogen; or a pharmaceutically acceptable salt or a solvate thereof. |
地址 |
Little Island, Co Cork IE |